Aceruloplasminemia with a novel mutation associated with parkinsonism
- PMID: 10983721
- DOI: 10.1007/s100489900082
Aceruloplasminemia with a novel mutation associated with parkinsonism
Similar articles
-
Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.Clin Genet. 2014 Mar;85(3):300-1. doi: 10.1111/cge.12145. Epub 2013 Apr 5. Clin Genet. 2014. PMID: 23557349 No abstract available.
-
Estimation of the gene frequency of aceruloplasminemia in Japan.Neurology. 1999 Aug 11;53(3):617-9. doi: 10.1212/wnl.53.3.617. Neurology. 1999. PMID: 10449129
-
Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene.Intern Med. 2003 Jul;42(7):599-604. doi: 10.2169/internalmedicine.42.599. Intern Med. 2003. PMID: 12879954
-
The iron-copper connection: the link to ceruloplasmin grows stronger.Nutr Rev. 1995 Jun;53(6):170-3. doi: 10.1111/j.1753-4887.1995.tb01545.x. Nutr Rev. 1995. PMID: 7478312 Review.
-
A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging.Arq Neuropsiquiatr. 2016 Jul;74(7):587-96. doi: 10.1590/0004-282X20160080. Arq Neuropsiquiatr. 2016. PMID: 27487380 Review.
Cited by
-
Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms.Neurochem Res. 2007 Oct;32(10):1646-54. doi: 10.1007/s11064-007-9346-5. Epub 2007 Apr 28. Neurochem Res. 2007. PMID: 17468954 Review.
-
Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.Neurotox Res. 2006 Jan;9(1):1-13. doi: 10.1007/BF03033302. Neurotox Res. 2006. PMID: 16464747 Review.
-
Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation.J Neurol. 2005 Jan;252(1):111-3. doi: 10.1007/s00415-005-0608-3. J Neurol. 2005. PMID: 15654567 No abstract available.
-
Iron in neurodegenerative disorders.Neurotox Res. 2002 Nov-Dec;4(7-8):637-653. doi: 10.1080/1029842021000045444. Neurotox Res. 2002. PMID: 12709302
-
Aceruloplasminemia with Abnormal Compound Heterozygous Mutations Developed Neurological Dysfunction during Phlebotomy Therapy.Intern Med. 2018 Sep 15;57(18):2713-2718. doi: 10.2169/internalmedicine.9855-17. Epub 2018 Apr 27. Intern Med. 2018. PMID: 29709961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources